An update of advanced nanoplatforms for Glioblastoma Multiforme Management

Authors

  • Mariana Amaral iMED.ULisboa, Research Institute for Medicines, Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal https://orcid.org/0000-0002-4526-2157
  • Nuno Cruz iMED.ULisboa, Research Institute for Medicines, Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal https://orcid.org/0000-0003-4196-6808
  • Ana Rosa Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal
  • Beatriz Nogueira Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal https://orcid.org/0000-0003-4800-6957
  • Diana Costa Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal https://orcid.org/0000-0003-4080-628X
  • Francisco Santos Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal https://orcid.org/0000-0002-0005-8435
  • Mariana Brazão Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal https://orcid.org/0000-0002-7528-1391
  • Pedro Policarpo Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal
  • Rita Mateus Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal https://orcid.org/0000-0003-4368-0889
  • Yan Kobozev Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal https://orcid.org/0000-0002-2255-4560
  • Catarina Pinto Reis iMED.ULisboa, Research Institute for Medicines, Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal. E-mail: catarinareis@ff.ulisboa.pt https://orcid.org/0000-0002-1046-4031

DOI:

https://doi.org/10.17179/excli2021-4393

Keywords:

Glioblastoma multiforme, nanosystems, superparamagnetic nanoparticles, polymeric nanoparticles, liposomes, gold nanoparticles

Abstract

Glioblastoma multiforme (GBM) is a very aggressive and heterogeneous glioma. Currently, GBM is treated with a combination of surgery, radiotherapy, chemotherapy (e.g. temozol­amide) and Tumour Treating Fields. Unfortunately, the mean survival is still around 15 months. This poor prognosis is associated with therapy resistance, tumor recurrence, and limited delivery of drugs due to the blood-brain barrier nature. Nanomedicine, the application of nanotechnology to medicine, has revolutionized many health fields, specifically cancer diagnosis and treatment. This review explores the particularities of different nanosystems (i.e., superparamagnetic, polymeric and gold nanoparticles, and liposomes) as well as how they can be applied to the treatment and diagnosis of GBM. As described, the most of the cited examples are on the preclinical phase; however, positive results were obtained and thus, the distance to achieve an effective treatment is shorter every day.

Author Biography

Catarina Pinto Reis, iMED.ULisboa, Research Institute for Medicines, Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal. E-mail: catarinareis@ff.ulisboa.pt

Catarina Pinto Reis is currently Professor at Faculty of Pharmacy (University of Lisbon). She is a member of Imed-ULisboa and collaborator at IBEB (FCUL) research group. She is also an external consultant of Infarmed.

During 2007 to Feb 2017, she was Assistant Professor of Pharmaceutical Technology I/II and Drug Delivery Systems in the School of Sciences and Health Technologies at the Universidade Lusófona de Humanidades e Tecnologias (Lisbon, Portugal).

She attended the University of Coimbra (Coimbra, Portugal) and graduated in Pharmaceutical Sciences. Her doctoral studies were also undertaken at the University of Coimbra with several important international collaborations where she developed an interest in advanced drug delivery systems. Those studies have been recognized through a number of national prizes. She finished her PhD in Pharmacy in 2008 as Distinguished Honor Graduate.

Since then, she has continued to work in the design and evaluation of nanoparticles and microparticles for peptide drug delivery. She is author or co-author of several articles, book chapters and inventor of patents.

Downloads

Published

2021-11-15

How to Cite

Amaral, M., Cruz, N., Rosa, A., Nogueira, B., Costa, D., Santos, F., … Reis, C. P. (2021). An update of advanced nanoplatforms for Glioblastoma Multiforme Management. EXCLI Journal, 20, 1544–1570. https://doi.org/10.17179/excli2021-4393

Issue

Vol. 20 (2021)

Section

Review articles

License

Copyright (c) 2021 Mariana Amaral, Nuno Cruz, Ana Rosa, Beatriz Nogueira, Diana Costa, Francisco Santos, Mariana Brazão, Pedro Policarpo, Rita Mateus, Yan Kobozev, Catarina Pinto Reis

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in this journal agree to the following terms:

  • The authors keep the copyright and grant the journal the right of first publication under the terms of the Creative Commons Attribution license, CC BY 4.0. This licencse permits unrestricted use, distribution and reproduction in any medium, provided that the original work is properly cited.
  • The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
  • Because the advice and information in this journal are believed to be true and accurate at the time of publication, neither the authors, the editors, nor the publisher accept any legal responsibility for any errors or omissions presented in the publication. The publisher makes no guarantee, express or implied, with respect to the material contained herein.
  • The authors can enter into additional contracts for the non-exclusive distribution of the journal's published version by citing the initial publication in this journal (e.g. publishing in an institutional repository or in a book).

Most read articles by the same author(s)